RegisterLogin

AZD0516

CAT: 0804-HY-173639-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-173639-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AZD0516 is a first-in-class antibody-drug conjugate (ADC) targeting six-transmembrane epithelial antigen of the prostate-2 (STEAP2) . The anti-STEAP2 monoclonal antibody (mAb) is conjugated via interchain cysteines to a maleimide-reactive, β-glucuronidase-cleavable linker (HY-173635) bearing the topoisomerase 1 inhibitor, Exatecan (HY-13631) . AZD0516 can be used for the study of prostate cancer[1].
UNSPSC
12352211
Target
Antibody-Drug Conjugates (ADCs) ; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
95.82
Smiles
[AZD0516]
References & Citations
[1]1158-Preclinical characterization of AZD0516, a novel STEAP2 antibody-drug conjugate (ADC) for the treatment of prostate cancer. AACR Annual Meeting 2025 Itinerary Planner Home.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-100016-01AZD0156
HY-100016RAZD0156 (Standard)
HY-16079-01AZD3514
HY-19427AZD9056
HY-120078-01AZD2716
HY-19427A-01AZD9056 (hydrochloride)

Alternative Products

CatalogName
T9901A-959-01AZD0516
HA962016-01Research Grade Anti-Human STEAP2 Antibody (AZD0516)
A137477Anti-STEAP2 Antibody (AZD0516) Biosimilar (Monoclonal, IgG1, kappa)

Popular Products